Kanagawa, Japan

Mizuki Tamori

This inventor holds 1 USPTO granted patent. Top assignee: Ajinomoto Co., Ltd.. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Mizuki Tamori. Retrieved from https://idiyas.com/inventor/mizuki-tamori

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Mizuki Tamori: Innovator in Enzyme Technology

Introduction

Mizuki Tamori is a prominent inventor based in Kanagawa, Japan. She has made significant contributions to the field of enzyme technology, particularly in the production of imidazole dipeptides. Her innovative work has garnered attention in both academic and industrial circles.

Latest Patents

Mizuki Tamori holds a patent for a "Modified Enzyme and Method of Producing Imidazole Dipeptide Using Same." This patent highlights her expertise in enzymatic processes and their applications in biochemistry.

Career Highlights

Tamori is currently employed at Ajinomoto Co., Ltd., a leading company in the food and biotechnology sectors. Her role at Ajinomoto allows her to apply her research in practical settings, contributing to advancements in food science and health.

Collaborations

Throughout her career, Mizuki has collaborated with notable colleagues, including Uno Tagami and Hiroyuki Nozaki. These partnerships have fostered a collaborative environment that enhances innovation and research outcomes.

Conclusion

Mizuki Tamori's work exemplifies the impact of innovative thinking in enzyme technology. Her contributions continue to influence the field and inspire future research endeavors.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…